Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9185099 | 1.00 | — | — | |
| SCHEMBL755068 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL9191751 | 0.91 | — | — | |
| SCHEMBL756020 | 0.86 | — | — | |
| SCHEMBL2223228 | 0.82 | ODC1 (0.60) | — | |
| SCHEMBL10776208 | 0.82 | ODC1 (0.60) | — | |
| SCHEMBL21357744 | 0.82 | ODC1 (0.60) | — | |
| SCHEMBL21357864 | 0.82 | ODC1 (0.60) | — | |
| SCHEMBL9185840 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL2728929 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024222981-A1 | ESTER CONJUGATE OF SPHINGOLIPID AND HYALURONAN, METHOD OF SYNTHESIS THEREOF, COMPOSITION CONTAINING THEREOF, USE OF CONJUGATE OR COMPOSITION | CONTIPRO A.S. (CZ) | 2024-10-31 | — | — | WO | disclosed |
| EP-4426752-A1 | HYDROGELS FOR ORGANOID CULTURE | Universiteit Maastricht (NL) | 2024-09-11 | — | — | EP | disclosed |
| US-20240034827-A1 | AQUEOUS DISPERSION COMPRISING ALPHA EFFECT BASED NUCLEOPHILE | PPG INDUSTRIES OHIO, INC. (US) | 2024-02-01 | — | — | US | disclosed |
| US-20230398040-A1 | A MULTI-LAYERED SHEET MASK | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-12-14 | — | — | US | disclosed |
| EP-4240202-A1 | A MULTI-LAYERED SHEET MASK | National University of Singapore (SG) | 2023-09-13 | — | — | EP | disclosed |
| WO-2023073244-A1 | HYDROGELS FOR ORGANOID CULTURE | UNIVERSITEIT MAASTRICHT (NL) | 2023-05-04 | — | — | WO | disclosed |
| WO-2022098314-A1 | A MULTI-LAYERED SHEET MASK | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2022-05-12 | — | — | WO | disclosed |
| US-20210102873-A1 | Fluorescent Dyes, Fluorescent Dye Kits, and Methods of Preparing Labeled Molecules | BIOTIUM, INC. | 2021-04-08 | — | — | US | disclosed |
| US-10837881-B2 | Fluorescent dyes, fluorescent dye kits, and methods of preparing labeled molecules | BIOTIUM, INC. (US) | 2020-11-17 | — | — | US | disclosed |
| EP-2686680-B1 | FLUORESCENT DYES, FLUORESCENT DYE KITS, AND METHODS OF PREPARING LABELED MOLECULES | BIOTIUM INC (US) | 2018-06-13 | — | — | EP | disclosed |
| EP-3148511-A1 | CROSS-LINKED HYALURONIC ACID GRAFTED WITH DEXTRAN | Galderma S.A. (CH) | 2017-04-05 | — | — | EP | disclosed |
| WO-2015181369-A1 | CROSS-LINKED HYALURONIC ACID GRAFTED WITH DEXTRAN | GALDERMA S.A. (CH) | 2015-12-03 | — | — | WO | disclosed |
| US-9018166-B2 | Conjugated FVIII variants | NOVO NORDISK A/S (DK) | 2015-04-28 | — | — | US | disclosed |
| US-20150056632-A1 | FLUORESCENT DYES, FLUORESCENT DYE KITS, AND METHODS OF PREPARING LABELED MOLECULES | BIOTIUM, INC. (US) | 2015-02-26 | — | — | US | disclosed |
| US-8709830-B2 | Fluorescent dyes, fluorescent dye kits, and methods of preparing labeled molecules | BIOTIUM, INC. (US) | 2014-04-29 | — | — | US | disclosed |
| EP-2686680-A1 | FLUORESCENT DYES, FLUORESCENT DYE KITS, AND METHODS OF PREPARING LABELED MOLECULES | Biotium Inc. (US) | 2014-01-22 | — | — | EP | disclosed |
| US-20120329068-A1 | FLUORESCENT DYES, FLUORESCENT DYE KITS, AND METHODS OF PREPARING LABELED MOLECULES | BIOTIUM, INC. (US) | 2012-12-27 | — | — | US | disclosed |
| US-20120322738-A1 | CONJUGATED FVIII VARIANTS | NOVO NORDISK A/S (DK) | 2012-12-20 | — | — | US | disclosed |
| WO-2012129128-A1 | FLUORESCENT DYES, FLUORESCENT DYE KITS, AND METHODS OF PREPARING LABELED MOLECULES | BIOTIUM, INC. (US) | 2012-09-27 | — | — | WO | disclosed |
| US-20100197573-A1 | Transglutaminase Mediated Conjugation of Growth Hormone | NOVO NORDISK HEALTH CARE AG (CH) | 2010-08-05 | — | — | US | disclosed |